Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5256134010 | Oteracil potassium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5256135011 | Oteracil potassium (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oteracil potassium | Is a | Triazine derivative (substance) | true | Inferred relationship | Some | ||
| Oteracil potassium | Is a | Monocarboxylate (substance) | true | Inferred relationship | Some | ||
| Oteracil potassium | Is a | Orotate phosphoribosyltransferase inhibitor | true | Inferred relationship | Some | ||
| Oteracil potassium | Has disposition (attribute) | Orotate phosphoribosyltransferase inhibitor | true | Inferred relationship | Some | ||
| Oteracil potassium | Is modification of (attribute) | Oteracil | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule | Has precise active ingredient | True | Oteracil potassium | Inferred relationship | Some | 2 |
| Product containing precisely gimeracil 5.8 milligram and oteracil (as oteracil potassium) 15.8 milligram and tegafur 20 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Oteracil potassium | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR